News about soaring drug prices rival health insurance premium increases for media attention to healthcare these days. Mylan Pharmaceuticals’ 461% price increase (2007-2014) for its EpiPens is the latest call-out…
Stay informed with Paul’s unique perspective on healthcare happenings, from policies and politics to innovations and investments. Subscribe today to the Keckley Report and be the first to receive Paul’s weekly insights and special reports.